Logo
Logo

With over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI). We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.

Dr. Reddy’s Approach in Handling HPAPIs

Reddy’s approach for high-potent APIs involves the following process:

Step 1

Evaluating the hazard of exposure to a compound and calculating the OEL levels

Step 2

Selecting the appropriate containment strategy for development and manufacturing based on scale

Step 3

Choosing proper engineering controls such as ventilation, chemical contaminants, etc.

Reddy’s approach for high-potent APIs involves the following process:

Step 4

Selecting the appropriate equipment and procedures, including PPE Sampling & weighing, blending, and drying

Step 5

Define Packaging needs to meet the requirements Capsule/Blistering Injectables

call big icon

We are here to help, if you have any country specific requirements.

From initial stages of development to commercialization, our team of scientists, quality, regulatory, supply chain, and analytical experts work collaboratively to meet our global clients' HPAPI requirements.

As an integrated HPAPI supplier, we have best-in-class cGMP manufacturing facilities for APIs and finished dosage forms. With our integrated R&D capabilities and infrastructure, we are well-positioned to support our customers to bring their products to the market faster. In addition, our rigorous safety, health, and environmental (SHE) practices, together with Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls, are established to protect workers, materials, machines, and the environment.

Facilities for handling HPAPIs

Dr. Reddy’s can handle molecules of OEL up to 0.1 µg/m3 at the following facilities:

  • cGMP compliant isolator systems (OEL 0.1µg/m³) for high potent raw materials, intermediates charging, filtration and drying, dispensing and packaging
  • Reaction mass transfer through closed loop lines
  • Rapid transfer ports for solid material transfer
  • HVAC system with zone classification to avoid cross-contamination
  • EPA filtered air
  • Multiple utilities cooling tower water, hot water, chilled brine, nitrogen, compressed air & steam
  • Differential pressure system with temperature and humidity control
Contact

Contact Us

Please fill out the following form. We will get back to you shortly.

Phone

FAQs

What is the minimum OEL that Dr. Reddy's can handle?
  • We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.

What experience does Dr. Reddy's have in producing HPAPIs?
  • With over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI).

What are our Quality Control (QC) capabilities for HPAPIs Manufacturing?
  • Our manufacturing sites are complemented by our analytical cGMP labs for QC and QA.

How do FDA or regulatory authorities inspect our HPAPIs?
  • Manufacturing plants are regularly inspected/audited by international regulatory authorities and numerous customers.

What factors are involved in the safety scale-up synthesis of an HPAPI drug substance in Dr. Reddy's?
  • We enable the best safety and healthy environmental practices through Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls for workers, material, machines, and environment.

What is the containment strategy performed for HPAPIs in Dr. Reddy's?
  • Top-class safety practices and containment control strategy in place.

    1. HVAC system with zone classification to avoid cross-contamination
    2. Choosing proper engineering controls such as ventilation, chemical contaminants, etc

Disclaimer

No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.